TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.

ETFs Tibet Rhodiola Pharmaceutical Holding Co.

600211

CNE000000ZW7

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-10-23			5-day change	1st Jan Change
36.13 ^CNY	+1.77%		+0.31%	-15.09%

10-08	Tranche Update on Tibet Rhodiola Pharmaceutical Holding Co.'s Equity Buyback Plan announced on December 18, 2025.	CI
08-13	Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

ETFs positioned on Tibet Rhodiola Pharmaceutical Holding Co.

Name	YTD change	Weight	AuM
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+4.28%	-	37 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+12.52%	-	9,273 M€
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP ETF - USD	+4.20%	0%	12,001 M€
VANGUARD FTSE EMERGING MARKETS ALL CAP INDEX ETF - CAD	+7.75%	0%	3,276 M€
VANGUARD FTSE EMERGING MARKETS SHARES ETF - AUD	-0.98%	0%	1,449 M€
VANGUARD FTSE EMERGING MARKETS ETF - USD	+5.73%	0%	126,032 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF ACC - USD	+14.39%	0%	117 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF DIST - USD	+12.49%	0%	24 M€
DEFINED DURATION 20 ETF - USD	+10.19%	0%	19 M€
VANGUARD TOTAL INTERNATIONAL STOCK ETF - USD	+9.40%	0%	163,510 M€
CAMBRIA GLOBAL MOMENTUM ETF - USD	+14.50%	0%	73 M€
ELM MARKET NAVIGATOR ETF - USD	+6.76%	0%	594 M€
VANGUARD TOTAL WORLD STOCK ETF - USD	+10.52%	0%	81,610 M€
VANGUARD FTSE GLOBAL ALL CAP EX CANADA INDEX ETF - CAD	+12.40%	0%	2,612 M€
RETURN STACKED GLOBAL STOCKS & BONDS ETF - USD	+6.05%	0%	526 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+13.74%	0%	12,086 M€
RPAR RISK PARITY ETF - USD	+0.64%	0%	580 M€
THE BRINSMERE FUND GROWTH ETF - USD	+7.34%	0%	391 M€
VANGUARD GROWTH ETF PORTFOLIO - CAD	+9.53%	0%	7,793 M€
UPAR ULTRA RISK PARITY ETF - USD	-0.86%	0%	59 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+6.33%	0%	4,204 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
CCM GLOBAL EQUITY ETF - USD	+13.90%	0%	1,199 M€
THE BRINSMERE FUND CONSERVATIVE ETF - USD	+1.58%	0%	363 M€
VANGUARD RETIREMENT INCOME ETF PORTFOLIO - CAD	+0.85%	0%	267 M€
VANGUARD CONSERVATIVE ETF PORTFOLIO - CAD	+3.09%	0%	688 M€
CLEARSHARES OCIO ETF - DISTRIBUTING - USD	+7.14%	0%	176 M€
VANGUARD CONSERVATIVE INCOME ETF PORTFOLIO - CAD	+0.04%	0%	184 M€
CAMBRIA GLOBAL EW ETF - USD	+7.40%	0%	146 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+11.86%	0%	62 M€
ACTIVEPASSIVE INTERNATIONAL EQUITY ETF - USD	+6.76%	0%	1,166 M€

Tibet Rhodiola Pharmaceutical Holding Co is a China-based company mainly engaged in the business of pharmaceutical manufacturing and pharmaceutical trading. The Company operates two segments, including the Pharmaceutical Manufacturing segment and the Pharmaceutical Trading segment. The Company mainly produces and sells capsules, biological preparations, granules, film coatings, and others. The Company's main products involve cardiovascular and cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds and other fields. The Company mainly conducts businesses within the domestic market.

Employees

671

Sector

Pharmaceuticals

Calendar

10-30 Earnings release - Q3 2026

More about the company